Advertisement

Index by author

November 01, 2019; Volume 371,Issue 2

  1. Adham, Nika

    1. The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879

  2. Ando, Ayumi

    1. A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846

  3. Andrews, Paul S.

    1. Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105

  4. Arman, Tarana

    1. A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489

  5. Aube, Jeffrey

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
Back to top

In this issue

Advertisement